Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity

Diabetes, Obesity and Metabolism

Volumn 9, Issue 5, 2007, Pages 761-763

  Haider, D G ^a   Schindler, K ^a   Bohdjalian, A ^a   Prager, G ^a   Luger, A ^a   Wolzt, M ^a   Ludvik, Bernhard ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GASTRIC BANDING; HUMAN; INSULIN SENSITIVITY; MALE; METABOLIC SYNDROME X; MORBID OBESITY; PROTEIN BLOOD LEVEL; RATING SCALE; WEIGHT REDUCTION;

EID: 34547916094     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2007.00717.x     Document Type: Article

References (5)

1. Xu A, Wang Y, Xu JY et al. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 2006; 52: 405-413.
2. Makowski L, Hotamisligil GS. Fatty acid binding proteins - the evolutionary crossroads of inflammatory and metabolic responses. J Nutr 2004; 134: 2464S-2468S.
3. Hertzel AV, Bernlohr DA. The mammalian fatty acid-binding protein multigene family: Molecular and genetic insights into function. Trends Endocrinol Metab 2000; 11: 175-180.
4. Maeda K, Cao H, Kono K et al. Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab 2005; 1: 107-119.
5. Maeda K, Uysal KT, Makowski L et al. Role of the fatty acid binding protein mal1 in obesity and insulin resistance. Diabetes 2003; 52: 300-307.